Eltanexor (KPT-8602)
For research use only.
Catalog No.S8397 Synonyms: ONO-7706,ATG-016
6 publications

CAS No. 1642300-52-4
Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.
Purity & Quality Control
Choose Selective CRM1 Inhibitors
Biological Activity
Description | Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
In vitro |
KPT-8602 is a potent inhibitor of AML cells in cell-based viability assays[1]. KPT-8602 inhibits XPO1/cargo interactions and nuclear export, induces apoptosis of primary CLL cells and significantly inhibits proliferation of diffuse large B-cell lymphoma cell lines[2] |
|||||
Assay |
|